European Journal of Internal Medicine

Papers
(The H4-Index of European Journal of Internal Medicine is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-01-01 to 2024-01-01.)
ArticleCitations
The pivotal link between ACE2 deficiency and SARS-CoV-2 infection901
Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study311
Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis283
Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19)274
Impact of low dose tocilizumab on mortality rate in patients with COVID-19 related pneumonia203
Creatinine: From physiology to clinical application150
Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy144
Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease137
Factors associated with mortality in patients with COVID-19. A quantitative evidence synthesis of clinical and laboratory data126
Electrocardiographic features of patients with COVID-19 pneumonia102
Incidence of acute pulmonary embolism in COVID-19 patients: Systematic review and meta-analysis.97
SARS-CoV-2 vaccines: Lights and shadows88
Mobile health technology-supported atrial fibrillation screening and integrated care: A report from the mAFA-II trial Long-term Extension Cohort85
Hepatic consequences of COVID-19 infection. Lapping or biting?78
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study63
Anakinra for patients with COVID-19: a meta-analysis of non-randomized cohort studies.60
Protective role of chronic treatment with direct oral anticoagulants in elderly patients affected by interstitial pneumonia in COVID-19 era59
Understanding the impact of chronic obstructive pulmonary disease exacerbations on patient health and quality of life55
Inhalation therapy devices for the treatment of obstructive lung diseases: the history of inhalers towards the ideal inhaler51
Factors associated with persistence of symptoms 1 year after COVID-19: A longitudinal, prospective phone-based interview follow-up cohort study47
SARS-CoV-2 antibody kinetics eight months from COVID-19 onset: Persistence of spike antibodies but loss of neutralizing antibodies in 24% of convalescent plasma donors47
Prospective blinded Evaluation of the smartphone-based AliveCor Kardia ECG monitor for Atrial Fibrillation detection: The PEAK-AF study45
The 2020 International Society of Hypertension global hypertension practice guidelines - key messages and clinical considerations45
Long-term efficacy of maintenance therapy with Rituximab for IgG4-related disease45
SARS-CoV-2 detection in the pericardial fluid of a patient with cardiac tamponade43
Bleeding in COVID-19 severe pneumonia: The other side of abnormal coagulation pattern?43
Mechanisms of weight regain.41
The pivotal link between ACE2 deficiency and SARS-CoV-2 infection: One year later40
Low serum albumin: A neglected predictor in patients with cardiovascular disease40
Uric acid in metabolic syndrome: Does uric acid have a definitive role?39
Prognostic impact of coronary microvascular dysfunction in patients with myocardial infarction with non-obstructive coronary arteries39
The Brain-Gut-Microbiotal Axis: A framework for understanding functional GI illness and their therapeutic interventions39
Beyond the 2020 guidelines on atrial fibrillation of the European society of cardiology38
Point-of-care ultrasound in internal medicine: A position paper by the ultrasound working group of the European federation of internal medicine38
Tocilizumab for the treatment of immune-related adverse events: a systematic literature review and a multicentre case series37
Blood pressure increase after Pfizer/BioNTech SARS-CoV-2 vaccine36
0.025442838668823